Sophisticated backtesting is not only possession of high-esteemed hedge funds anymore.
Impressive Team and support, Backtesting engine with detailed reports, The Strategy builder.
Great purchase!
I have always manually invested in stocks and cryptocurrencies, but after studying Vestinda, I must say it has enormous potential.
Mature platform for trading
Pro: Easy to use, Nice UX, A lot of customization for strategies, Back testing is an awesome tool, can check any strategy in history.
Quantitative Strategies & Backtesting results for CDNA
Here are some CDNA trading strategies along with their past performance. You can validate these strategies (and many more) for free on Vestinda across thousands of assets and many years of historical data.
Quantitative Trading Strategy: Lock and keep profits on CDNA
Based on the backtesting results, which spanned from November 5, 2016, to November 5, 2023, the trading strategy showcased promising performance. The strategy displayed a profit factor of 1.18 and an annualized return on investment (ROI) of 43.38%. On average, the holding time for trades was approximately 9 weeks and 2 days, while the strategy executed an average of 0.04 trades per week. Out of a total of 17 closed trades, the winning trades percentage amounted to 29.41%. Significantly, the strategy outperformed the buy-and-hold approach, generating excess returns of 143.58%. Overall, these statistics demonstrate the potential effectiveness and profitability of the trading strategy.
CDNA
Choose another period and try again.
Quantitative Trading Strategy: Template BB RSI on CDNA
Based on the backtesting results for a trading strategy conducted over the period from November 5, 2022, to November 5, 2023, several key statistics have emerged. The profit factor, a measure of profitability, stands at an impressive 2.97. Additionally, the annualized return on investment (ROI) is recorded at a remarkable 41.18%. The average holding time for trades comes out to 2 days and 13 hours, while an average of 0.21 trades per week were executed. There were a total of 11 closed trades during this period, with a winning trades percentage of 72.73%. Most notably, this strategy outperformed a buy and hold approach, generating excess returns of 237.75%.
CDNA
Choose another period and try again.
Golden Cross with CDNA: Step-by-Step Usage Guide
- Identify the 50-day moving average (MA) and the 200-day MA for CDNA stock.
- Wait for the 50-day MA to cross above the 200-day MA, forming a "golden cross".
- Confirm the golden cross by observing increasing trading volume.
- Consider the golden cross as a bullish signal for CDNA, indicating potential upward momentum.
- Monitor price action and observe if the stock starts trending higher after the golden cross.
- Place a buy order if the price confirms the bullish signal and the overall market conditions are favorable.
- Set a stop-loss order to manage risk and protect against potential downside.
CDNA Golden Cross Analysis
The Golden Cross is a significant technical analysis indicator that occurs when a short-term moving average crosses above a long-term moving average. It is typically used by traders and investors to identify potential bullish trends in the market. In the case of CDNA, the components of the Golden Cross include the shorter-term 50-day moving average and the longer-term 200-day moving average. When the 50-day moving average for CDNA crosses above the 200-day moving average, it signals a potential buying opportunity. This implies that the stock's short-term price momentum is surpassing its long-term trend, potentially indicating a shift towards a bullish trend. Traders often see this as a positive signal and may consider entering a long position on CDNA.
Caredx Inc.: A Comprehensive CDNA Snapshot
Caredx Inc., commonly known as CDNA, is a leading molecular diagnostics company. They specialize in transplant diagnostics to improve patient outcomes after organ transplantation. CDNA offers a comprehensive portfolio of innovative solutions for solid organ transplant patients and their physicians. Their testing services include monitoring the rejection of transplanted organs, identifying post-transplant infections, and assessing the risk of rejection. With advanced technology and a strong commitment to research and development, CDNA continues to revolutionize the field of transplant diagnostics. Through their diagnostic insights, physicians can make more informed decisions and optimize patient care. CDNA’s mission is to provide accurate and timely information to enhance transplant patient management, ultimately prolonging graft survival and improving patients’ quality of life. With their dedication to innovation and patient well-being, CDNA remains at the forefront of the transplant diagnostics industry.
Decoding CDNA: Harnessing Technical Analysis's Power
Technical analysis is crucial for investors in order to make informed decisions about buying or selling stocks. It helps in identifying trends and patterns in stock prices, which can provide insights into future price movements. CDNA, for example, could have been identified as a potential investment opportunity through technical analysis. By analyzing historical price data and various technical indicators, such as moving averages and volume, investors can gauge the strength of a stock's trend and predict potential price reversals. Technical analysis also helps in setting price targets and determining optimal entry and exit points. It provides a systematic approach to analyzing stocks and can be used in conjunction with other forms of analysis to make well-informed investment decisions.
-
Create
account -
Discover profitable
strategies -
Connect exchange
& start earning
Frequently Asked Questions
Yes, there are several Golden Cross trading courses and tutorials available for CDNA enthusiasts. These courses provide comprehensive guidance on understanding and implementing the Golden Cross trading strategy specifically for CDNA stocks. They cover topics ranging from technical analysis and chart patterns to risk management and trade execution. These courses are designed to help CDNA enthusiasts make informed trading decisions based on the Golden Cross indicator, which involves the crossing of short-term and long-term moving averages. By attending these courses or following tutorials, CDNA enthusiasts can enhance their trading skills and gain valuable insights into the Golden Cross strategy for successful trading.
The Golden Cross, a bullish technical analysis tool, can be compared to other indicators for CDNA such as the MACD or RSI. While the Golden Cross relies on the crossover of short-term and long-term moving averages to signal a potential uptrend, the MACD measures momentum and the RSI identifies overbought or oversold conditions. Both the MACD and RSI provide different insights into CDNA's price action and market sentiment compared to the Golden Cross. Traders may consider utilizing a combination of these tools to obtain a more comprehensive analysis of CDNA's technical signals.
The Golden Cross is a bullish technical signal that occurs when a short-term moving average, such as the 50-day moving average, crosses above a long-term moving average, such as the 200-day moving average. In the context of CDNA market sentiment indexes, a Golden Cross could suggest a positive market sentiment shift, indicating a potential uptrend in the index. It may signify a buying opportunity for investors and be considered as a favorable signal for CDNA market sentiment indexes. However, it is essential to conduct thorough analysis and consider other factors before making investment decisions.
The Golden Cross, a technical analysis indicator, refers to the crossing of a shorter-term moving average over a longer-term moving average, indicating a bullish trend. The impact on short-term versus long-term capital gains tax implications for CDNA traders is not directly influenced by the Golden Cross. Instead, the holding period of the asset determines the tax treatment. Short-term gains (held for less than a year) are usually subject to higher tax rates as per the individual's income bracket, while long-term gains (held for over a year) receive advantageous tax rates, typically lower. The Golden Cross does not alter these tax implications but may serve as a signal for potential trading strategies.
Conclusion
In conclusion, CDNA Golden Cross Trading is a popular strategy used by traders and investors to identify potential buying opportunities in the stock market. By analyzing CDNA's Golden Cross Trading charts and using technical analysis indicators such as moving averages, traders can gain insights into the stock's trend and make informed decisions. Caredx Inc., commonly known as CDNA, is a leading molecular diagnostics company specializing in transplant diagnostics. Through their innovative solutions, CDNA aims to improve patient outcomes after organ transplantation. Technical analysis is crucial for investors to make well-informed investment decisions, and CDNA presents itself as a potential investment opportunity through the analysis of its stock price trends and indicators.
Successful traders rely on backtesting to be profitable.
Be like them with our
Free Backtesting Guide